CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 8-K Event Other events
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 10-K/A Report 10-K/A
- 8-K Event Other events
- 424B3 Offering Prospectus
- 8-K Event Results of operations · Regulation FD disclosure
- 10-K Report Annual Report
- D Other Notice of Sales of Unregistered Securities
- 424B3 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 424B3 Offering Prospectus
- 8-K Event Executive or director change · Other events
- 8-K Event Executive or director change · Other events
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Open-market buy Chairman and Chief Scientist bought 40,000 shares at $1.17 ($46,800)
Page 4 of 24 · 479 filings